Last updated on February 2018

Study in Subjects With Light Chain (AL) Amyloidosis

Brief description of study

The objective of this study is to evaluate the long-term safety and efficacy of NEOD001 in subjects with AL amyloidosis who have completed Study NEOD001-201.

Detailed Study Description

Global, multicenter, Phase 2b, open-label extension study of subjects with AL amyloidosis who had a hematologic response to first-line treatment for their amyloidosis (e.g., chemotherapy, autologous stem cell transplant [ASCT]) and completed Study NEOD001-201. Subjects in this study may receive concomitant chemotherapy. Subject screening will occur during the 28 days prior to the first administration of study drug, which may overlap with the last visit in Study NEOD001-201. If all eligibility requirements are met, the subject will be enrolled and Screening assessments will be completed. Study visits will occur every 28 days based on scheduling from Month 1 Day 1. A 5-day window is allowed for visits starting after Month 1. Subjects who discontinue study drug before the End of Study Visit (EOS) should have an Early Treatment Discontinuation Visit 30 (5) days after their final administration of study drug. Each subject's study participation may be up to 38 months or until the study is terminated, whichever occurs first. The study consists of a Screening Phase (1 month), Treatment Phase (36 months), and EOS Visit (30 [5] days after the last dose).

Clinical Study Identifier: NCT03154047

Contact Investigators or Research Sites near you

Start Over

Tara Gregory, MD

Colorado Blood Cancer Institute
Denver, CO United States
  Connect »

Taimur Sher, MD

Mayo Clinic Hospital - Florida
Jacksonville, FL United States
  Connect »

Raymond Comenzo, MD

Tufts Medical Center
Boston, MA United States
  Connect »

Jeffrey Zonder, MD

Karmanos Cancer Institute
Detroit, MI United States
  Connect »

Morie Gertz, MD

Mayo Clinic - Minnesota
Rochester, MN United States
  Connect »

Heather Landau, MD

Memorial Sloan-Kettering Cancer Center
New York, NY United States
  Connect »

Jason Valent, MD

Cleveland Clinic
Cleveland, OH United States
  Connect »

Stephen Heitner, MD

Oregon Health & Science University
Portland, OR United States
  Connect »

Adam Cohen, MD

Hospital of the University of Pennsylvania
Philadelphia, PA United States
  Connect »

Stacey Goodman, MD

Vanderbilt University Medical Center
Nashville, TN United States
  Connect »

Hans Lee, MD

The University of Texas MD Anderson Cancer Center
Houston, TX United States
  Connect »

Anita D'Souza, MD

Medical College of Wisconsin
Milwaukee, WI United States
  Connect »

Fiona Kwok, MD

Westmead Hospital
Sydney, Australia
  Connect »

Peter Mollee, MD

Princess Alexandra Hospital
Woolloongabba, Australia
  Connect »

Simon Gibbs, MD

Eastern Health (Box Hill Hospital)
Box Hill, Australia
  Connect »

Hermine Agis, MD

Medizinische Universit t Wien
Vienna, Austria
  Connect »

Arnaud Jaccard, MD

H pital Dupuytren - CHU Limoges
Limoges, France
  Connect »

Sylvain Choquet, MD

H pital Piti -Salp tri re
Paris, France
  Connect »

Axel Nogai, MD

Charit - Universit tsmedizin Berlin
Berlin, Germany
  Connect »

Alexander Carpinteiro, MD

University of Duisburg-Essen
Essen, Germany
  Connect »

Mascha Binder, MD

Universit tsklinikum Hamburg-Eppendorf (UKE)
Hamburg, Germany
  Connect »

Michael Rosenzweig, MD

City of Hope
Duarte, CA United States
  Connect »

Andrzej Jakubowiak, MD

University of Chicago Medicine
Chicago, IL United States
  Connect »

Rafat Abonour, MD

Indiana University Simon Cancer Center
Indianapolis, IN United States
  Connect »

Cristina Gasparetto, MD

Duke University Medical Center
Durham, NC United States
  Connect »

Stefan Schönland, MD

Universit tsklinikum Heidelberg
Heidelberg, Germany
  Connect »

Efstathios Kastritis, MD

Alexandra General Hospital of Athens
Athens, Greece
  Connect »

Anargyros Symeonidis, MD

University Hospital of Patras
Patras, Greece
  Connect »

Moshe Gatt, MD

Hadassah Medical Center (HMC)
Jerusalem, Israel
  Connect »

Giampaolo Merlini

Fondazione IRCCS Policlinico San Matteo
Pavia, Italy
  Connect »

Joan Blade, MD

Hospital Cl nic de Barcelona
Barcelona, Spain
  Connect »

Isabel Krsnik

Hospital Universitario Puerta de Hierro - Majadahonda
Majadahonda, Spain
  Connect »

Guy Pratt, MD

Queen Elizabeth Hospital
Birmingham, United Kingdom
  Connect »

Ashutosh Wechalekar, MD

The Royal Free Hospital
London, United Kingdom
  Connect »